Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

NCT01867879 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors (Excluding Breast Cancer)

Interventions

DRUG: TAS-102
DRUG: Placebo

Sponsor

Taiho Oncology, Inc.